|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/198 | |
| A61P 25/28 | |||
| A61P 25/24 | |||
| A61P 25/14 | |||
| A61P 25/04 |
| (11) | Patento numeris | 2948140 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 14743570.5 |
| Europos patento paraiškos padavimo data | 2014-01-22 | |
| (97) | Europos patento paraiškos paskelbimo data | 2015-12-02 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2017-05-10 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2014/012598 |
| Data | 2014-01-22 |
| (87) | Numeris | WO 2014/116739 |
| Data | 2014-07-31 |
| (30) | Numeris | Data | Šalis |
| 201361849191 P | 2013-01-22 | US |
| (72) |
SNODGRASS, H., Ralph, US
CATO, Allen, E., US
HICKLIN, Jack, S., US
|
| (73) |
Vistagen Therapeutics, Inc.,
343 Allerton Avenue, South San Francisco, CA 94080,
US
|
| (54) | DOSAGE FORMS AND THERAPEUTIC USES L-4-CHLOROKYNURENINE |
| DOSAGE FORMS AND THERAPEUTIC USES L-4-CHLOROKYNURENINE |